SLR HC BDC LLC Annual Report Summary (Fiscal Year Ended December 31, 2023)

This summary offers key insights into SLR HC BDC LLC's financial performance, investment strategy, and risk factors for the fiscal year ended December 31, 2023. Drawn from its recent 10-K filing, this information is vital for investors considering this non-traded Business Development Company (BDC).

Business Overview: Understanding SLR HC BDC LLC

SLR HC BDC LLC is a non-traded Business Development Company (BDC) that primarily seeks to generate current income and, secondarily, capital appreciation. As a BDC, it operates under the Investment Company Act of 1940, which permits investments in privately held, middle-market companies.

The company's core strategy involves providing senior secured loans to companies primarily within the healthcare and life sciences industries. Borrower assets typically back these loans, offering some principal protection. While debt is their primary focus, they also make opportunistic equity investments, such as common stock or warrants, which represent a smaller portion of their portfolio. They target established U.S. middle-market companies needing capital for growth, acquisitions, or recapitalizations.

Key industry sectors they invest in include:

• Health Care Providers & Services (e.g., United Digestive MSO Parent, LLC, Fertility (ITC) Investment Holdco, LLC, Pinnacle Fertility, Inc.)
• Health Care Equipment & Supplies (e.g., SunMed Group Holdings, LLC, Centinel Spine, LLC, Vapotherm, Inc.)
• Pharmaceuticals (e.g., Arcutis Biotherapeutics, Inc., Ardelyx, Inc.)
• Life Sciences Tools & Services (e.g., Treace Medical Concepts, Inc.)
• They also maintain limited exposure to Diversified Consumer Services (e.g., Western Veterinary Partners LLC).

Financial Performance and Investment Highlights (Fiscal Year 2023)

SLR HC BDC LLC achieved solid financial performance in fiscal year 2023, largely benefiting from its floating-rate loan portfolio in a rising interest rate environment. Here are the key highlights from its operations:

• Total Investment Income: The company generated approximately $185 million in total investment income, mostly from interest on its debt investments.
• Net Investment Income (NII): Net Investment Income (NII), a key BDC metric, reached approximately $92 million, or $1.35 per share. This income covers operating expenses and shareholder distributions.
• Net Asset Value (NAV): Net Asset Value (NAV) per share stood at $15.80 as of December 31, 2023, reflecting stable underlying investment valuations.
• Total Investment Portfolio: The investment portfolio's fair value grew to approximately $1.85 billion by year-end, spread across 120 portfolio companies.
• Distributions to Shareholders: The company declared and paid total distributions of $1.32 per share during the fiscal year, primarily funded by its Net Investment Income.
• Portfolio Composition: The portfolio heavily favors senior secured debt, which made up approximately 93% of total investments at fair value. Equity investments comprised the remaining 7%.
• Weighted Average Yield: The weighted average yield on income-producing debt investments was approximately 11.2% as of December 31, 2023, largely due to its predominantly floating-rate loans.
• Credit Quality: The company maintained a strong credit profile. Non-accrual loans (loans no longer recognizing interest payments) represented approximately 1.8% of the total portfolio at fair value by year-end.
• Leverage: The company's net debt-to-equity ratio was approximately 1.05x at year-end, within its regulatory limits and target leverage range.
• Fair Value Measurements: Approximately 88% of the portfolio falls under Level 3 in the fair value hierarchy. This means valuations rely on unobservable inputs and management judgment, a common characteristic for private credit investments.

Key Investment Strategy and Income Generation (MD&A Highlight)

SLR HC BDC LLC primarily earns income from interest payments on its senior secured loans. Most of these loans are floating-rate, meaning their interest rates adjust periodically based on a benchmark like the Secured Overnight Financing Rate (SOFR), plus a contractual spread. For instance, many loans are structured as "SOFR plus a spread" (e.g., SOFR + 5.75%), often resulting in current effective interest rates in the 9% to 11% range. This structure allowed the BDC to benefit from rising interest rates in 2023.

Recent loan examples from the portfolio as of December 31, 2023, include:

• A loan to United Digestive MSO Parent, LLC at an effective rate of 9.42%.
• A loan to Exactcare Parent, Inc. at an effective rate of 10.03%.
• A loan to CVAUSA Management, LLC at an effective rate of 10.84%.

Risk Factors for Investors

Prospective investors should carefully consider several inherent risks when investing in SLR HC BDC LLC:

• Non-Traded BDC Liquidity Risk: As a non-traded BDC, its shares have no active public trading market. Investors should view this as a long-term, illiquid investment. Share repurchases are typically limited and discretionary, which can make selling shares quickly or at a desired price difficult.
• Concentration in Healthcare and Life Sciences: The company's significant focus on healthcare and life sciences exposes it to specific industry risks. These risks include changes in government regulation (e.g., Medicare/Medicaid reimbursement policies), technological advancements, product liability, intellectual property disputes, and shifts in consumer demand or payment models. Adverse developments in these sectors could materially impact investment values.
• Credit Risk and Risk of Loss: As a lender, the primary risk is that portfolio companies may default on their loan obligations. While senior secured loans offer some protection, full recovery is not guaranteed. Economic downturns, industry-specific challenges, or poor management at portfolio companies could lead to loan defaults, non-accruals, and potential losses.
• Interest Rate Risk: While floating-rate loans can benefit from rising rates, a significant decline in benchmark interest rates (like SOFR) could reduce the company's investment income. Conversely, rapidly rising rates could increase portfolio companies' borrowing costs, potentially impacting their ability to service debt.
• Valuation Uncertainty (Level 3 Assets): A substantial portion of the portfolio's fair value relies on unobservable inputs (Level 3). This introduces subjectivity and judgment into the valuation process, and actual realized values could materially differ from reported fair values.
• Leverage Risk: As a BDC, SLR HC BDC LLC uses borrowed money (leverage) to finance its investments. While leverage can enhance returns, it also magnifies losses if investments decline. The company must adhere to regulatory leverage limits.
• Regulatory and Compliance Risk: As a BDC, the company must comply with specific regulations under the Investment Company Act of 1940 and maintain its tax status as a Regulated Investment Company (RIC). Failing to meet these requirements could have significant adverse consequences, including increased tax liabilities.
• Dependence on Management: The company's success largely depends on the expertise and performance of its investment adviser, SLR Capital Partners, LLC, and its key personnel.
• No Assurance of Cash Distributions: While the company aims to pay regular distributions, these are not guaranteed. Distributions depend on the company's performance, NII, and compliance with regulatory requirements. Distributions may also include a return of capital, which reduces an investor's cost basis.

Financial Health and Liquidity

SLR HC BDC LLC's financial health depends on its capital structure and ability to generate cash flow for operations, new investments, and distributions. As of December 31, 2023, the company maintained a net debt-to-equity ratio of approximately 1.05x. This ratio remained within its regulatory limits and target leverage range, demonstrating prudent use of borrowed capital.

The company's primary liquidity sources include cash flow from operations, mainly from interest and fee income from its investment portfolio and principal repayments on its debt investments. Additionally, the company typically accesses various credit facilities and other borrowing arrangements to fund new investments and manage short-term liquidity needs. The company's investment portfolio generally secures these facilities.

Generating consistent Net Investment Income and effectively managing leverage are crucial for maintaining financial flexibility and supporting its distribution policy.

Future Outlook and Strategy

Management expressed confidence in the company's disciplined investment approach and its focus on defensive, recession-resilient healthcare and life sciences sectors. For the upcoming fiscal year, the company plans to continue originating senior secured loans to middle-market companies, leveraging its industry expertise and relationships. Management anticipates the portfolio's floating-rate nature will continue to hedge against inflation and generate attractive current income for shareholders. They will also vigilantly monitor credit quality across the portfolio and prudently manage leverage. The company aims to maintain a consistent distribution policy, primarily funded by Net Investment Income.

Competitive Position

The middle-market debt and equity investment market is highly competitive. SLR HC BDC LLC competes with various financial institutions, including other BDCs, private equity funds, commercial banks, investment banks, and private credit funds.

The company's competitive advantages typically stem from:

• Specialized Industry Focus: Its deep expertise and relationships within healthcare and life sciences allow it to identify and underwrite attractive investment opportunities that generalist lenders might overlook.
• Relationship-Driven Sourcing: Leveraging the network and reputation of its investment adviser, SLR Capital Partners, LLC, to source proprietary deal flow.
• Flexible Capital Solutions: Ability to offer tailored financing solutions, including senior secured debt and opportunistic equity, which can be more attractive to middle-market companies than traditional bank financing.
• Credit Underwriting Expertise: A disciplined approach to credit analysis and structuring, aiming to mitigate risk while generating attractive returns.
• Access to Capital: The ability to raise capital through various debt and equity channels to support its investment activities.

Success in this competitive environment depends on effectively sourcing, evaluating, structuring, and monitoring investments, and maintaining strong relationships with borrowers and financial sponsors.